CLINICAL_TRIALS
trial_result
· 2020-04-02
Clinical Trial Update: Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia [Phase 3]
Summary
Phase 3 trial investigating whether vitamin D supplementation affects serum BDNF levels and cognitive function in schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universitas Padjadjaran | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN